MiR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3309-3316

  El Tayebi, H M ^a   Hosny, K A ^b   Esmat, G ^b   Breuhahn, K ^c   Abdelaziz, Ahmed Ihab ^a  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Heptocellular carcinoma; microRNA 615 5p; Migration; Proliferation

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MIR 615 5P; SOMATOMEDIN B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN TARGETING; RNA SEQUENCE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HEP G2 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER CIRRHOSIS; LIVER NEOPLASMS; LUCIFERASES; MICRORNAS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84866619677     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.06.054     Document Type: Article

References (25)

1. M. Chen, J. Zhang, N. Li, Z. Qian, M. Zhu, Q. Li, J. Zheng, X. Wang, and G. Shi Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer PLoS One 6 2011 e25564
2. Y. Feng, W.J. Xue, P. Li, Z.Y. Sha, H. Huang, L. Rui, H.X. Li, and Q.S. Mao RASSF1A Hypermethylation is associated with aflatioxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma Hepatogastroenterology 59 2011
3. Y. Jia, Y. Yang, S. Liu, J.G. Herman, F. Lu, and M. Guo SOX17 antagonizes WNT/beta-catenin signaling pathway in hepatocellular carcinoma Epigenetics 5 2010 743 749
4. L.M. Kong, C.G. Liao, L. Chen, H.S. Yang, S.H. Zhang, Z. Zhang, H.J. Bian, J.L. Xing, and Z.N. Chen Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma J. Cell Mol. Med. 15 2011 1415 1428
5. I.I. Ramzy, D.A. Omran, O. Hamad, O. Shaker, and A. Abboud Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma Arab. J. Gastroenterol. 12 2011 139 142
6. P. Arbuthnot, and L.J. Thompson Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma World J. Gastroenterol. 14 2008 1670 1681
7. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
8. Z.B. Han, H.Y. Chen, J.W. Fan, J.Y. Wu, H.M. Tang, and Z.H. Peng Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation J. Cancer Res. Clin. Oncol. 138 1 2012, Jan 153 161
9. Q. Xie, X. Chen, F. Lu, T. Zhang, M. Hao, Y. Wang, J. Zhao, M.A. McCrae, and H. Zhuang Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma Cancer 118 9 2012, May 1 2431 2442
10. Q. Ying, L. Liang, W. Guo, R. Zha, Q. Tian, S. Huang, J. Yao, J. Ding, M. Bao, and C. Ge Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma Hepatology 54 2011 2064 2075
11. J.K. Park, T. Kogure, G.J. Nuovo, J. Jiang, L. He, J.H. Kim, M.A. Phelps, T.L. Papenfuss, C.M. Croce, T. Patel, and T.D. Schmittgen MiR-221 silencing blocks hepatocellular carcinoma and promotes survival Cancer Res. 71 24 2011, Dec 15 7608 7616
12. M. Girard, E. Jacquemin, A. Munnich, S. Lyonnet, and A. Henrion-Caude MiR-122, a paradigm for the role of microRNAs in the liver J. Hepatol. 48 2008 648 656
13. Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X: MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene 2011, Nov 21. doi: 10.1038/onc.2011.523.
14. Q.W. Wong, R.W. Lung, P.T. Law, P.B. Lai, K.Y. Chan, K.F. To, and N. Wong MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 2008 257 269
15. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS: MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2011, Nov 7. doi: 10.1038/onc.2011.500.
16. T. Hulf, T. Sibbritt, E.D. Wiklund, S. Bert, D. Strbenac, A.L. Statham, M.D. Robinson, and S.J. Clark Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription BMC Genomics 12 2011, Jan 21 54
17. S. Liu, W. Guo, J. Shi, N. Li, X. Yu, J. Xue, X. Fu, K. Chu, C. Lu, and J. Zhao MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma J. Hepatol. 56 2 2012, Feb 389 396
18. J. Lin, S. Huang, S. Wu, J. Ding, Y. Zhao, L. Liang, Q. Tian, R. Zha, R. Zhan, and X. He MicroRNA-423 promotes cell growth and regulates G1/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma Carcinogenesis 32 11 2011, Nov 1641 1647
19. C. Zeng, R. Wang, D. Li, X.J. Lin, Q.K. Wei, Y. Yuan, Q. Wang, W. Chen, and S.M. Zhuang A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma Hepatology 52 2010 1702 1712
20. J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, Q. Dong, L. Qin, X. Wu, Y. Zheng, and Y. Yang Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma Cancer Cell 19 2011 232 243
21. X.H. Huang, J.S. Chen, Q. Wang, X.L. Chen, L. Wen, L.Z. Chen, J. Bi, L.J. Zhang, Q. Su, and W.T. Zeng MiR-338-3p suppresses invasion of liver cancer cell by targeting smoothened J. Pathol. 225 3 2011, Nov 463 472
22. S. Tan, R. Li, K. Ding, P.E. Lobie, and T. Zhu MiR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway FEBS Lett. 585 2011 2229 2234
23. T. Nussbaum, J. Samarin, V. Ehemann, M. Bissinger, E. Ryschich, A. Khamidjanov, X. Yu, N. Gretz, P. Schirmacher, and K. Breuhahn Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis Hepatology 48 2008 146 156
24. K. Breuhahn Molecular mechanisms of progression in human hepatocarcinogenesis Pathologe 31 Suppl 2 2010 170 176
25. P. Lund, D. Schubert, F. Niketeghad, and P. Schirmacher Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II Cancer Lett. 206 2004 85 96